Supernus Pharmaceuticals Inc (SUPN)
SG&A Expenses
$133.64M
Quarterly · Period ending: · USD
SUPN SG&A Expenses
Latest reported$133.64Mperiod ending
Latest reported$133.64Mperiod ending
SUPN Quarterly SG&A Expenses ($1.15M → $133.64M)
Quarterly SG&A Expenses
High-resolution chart · PNG
SUPN sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 133,637,000 | |
| 125,173,000 | |
| 122,390,000 | |
| 179,678,000 | |
| 93,551,000 | |
| 89,944,000 | |
| 79,409,000 | |
| 69,753,000 | |
| 85,904,000 | |
| 86,516,000 | |
| 81,282,000 | |
| 82,700,000 | |
| 86,782,000 | |
| 85,597,000 | |
| 73,972,000 | |
| 112,314,000 | |
| 100,476,000 | |
| 90,459,000 | |
| 101,735,000 | |
| 72,032,000 | |
| 69,535,000 | |
| 61,457,000 | |
| 56,300,000 | |
| 54,460,000 | |
| 48,103,000 | |
| 41,614,000 | |
| 35,725,000 | |
| 39,343,000 | |
| 39,777,000 | |
| 40,968,000 | |
| 42,050,000 | |
| 40,892,000 | |
| 40,097,000 | |
| 36,849,000 | |
| 33,764,000 | |
| 40,825,000 | |
| 35,078,000 | |
| 28,238,000 | |
| 29,055,000 | |
| 25,675,000 | |
| 26,121,000 | |
| 25,160,000 | |
| 23,566,000 | |
| 22,900,000 | |
| 23,336,000 | |
| 19,402,000 | |
| 18,018,000 | |
| 17,343,000 | |
| 19,581,000 | |
| 17,527,000 | |
| 15,223,000 | |
| 14,620,000 | |
| 12,214,000 | |
| 13,533,000 | |
| 8,684,000 | |
| 4,075,000 | |
| 4,645,000 | |
| 2,728,000 | |
| 2,785,000 | |
| 1,501,000 | |
| 1,895,000 | |
| 1,747,000 | |
| 1,691,232 | |
| 1,146,461 |